Developments in the Obesity Medication Market
April 29, 2025
The battle against obesity continues with various drugs competing in the market. Ozempic, initially popular for weight loss among diabetics, is losing its appeal as new medications like Wegovy from Novo Nordisk enter the scene. Eli Lilly is also making strides with its new drug, Monjaro, gaining prominence. This situation is reflected in Cyprus, where the introduction of obesity medications is becoming more attractive.